385 related articles for article (PubMed ID: 11570032)
1. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: synergy or null effect?
Am J Manag Care; 2001 Sep; 7(12 Suppl):S402-3. PubMed ID: 11570032
[TBL] [Abstract][Full Text] [Related]
2. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
3. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
[TBL] [Abstract][Full Text] [Related]
4. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
6. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
McColl KE
Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes].
Teixeira AV
Acta Med Port; 1995 Sep; 8(9):517-21. PubMed ID: 7484272
[TBL] [Abstract][Full Text] [Related]
9. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
[TBL] [Abstract][Full Text] [Related]
10. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and diagnosis of non-steroidal anti-inflammatory drugs induced ulcers of the stomach].
Watari J; Kim Y; Yokoyama S; Hori K; Miwa H
Nihon Rinsho; 2011 Jun; 69(6):1016-23. PubMed ID: 21688621
[TBL] [Abstract][Full Text] [Related]
12. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
Mohamed AH; Salena BJ; Hunt RH
J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
[TBL] [Abstract][Full Text] [Related]
13. [Duodenal ulcer: the current etiopathogenic concepts, acid hypersecretion? Helicobacter pylori? nonsteroidal anti-inflammatory drugs?].
Katz J; Corti RE; López Gastón A
Acta Gastroenterol Latinoam; 1992; 22(4):263-4. PubMed ID: 1340682
[No Abstract] [Full Text] [Related]
14. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
[TBL] [Abstract][Full Text] [Related]
15. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Lanas Arbeloa A; Serrano Aulló MT
Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
[No Abstract] [Full Text] [Related]
16. [What role today for Helicobacter pylori in peptic ulcer?].
Cadiot G
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
18. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
19. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
